This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Sildenafil
REVATIO, VIAGRA – Pfizer Canada Inc. (NOC Search)
Patents:
- 2044748: RATIOPHARM, , NOVOPHARM, APOTEX, MYLAN, SANDOZ, TEVA
- 2073226:
- 2163446: PHARMASCIENCE, , RATIOPHARM, APOTEX, NOVOPHARM, MYLAN, MINT, TEVA, SANDOZ
- 2262268: APOTEX, TEVA
- 2277017: MYLAN, TEVA
- 2285733: MYLAN, TEVA, RATIOPHARM
- 2290766: TEVA, MYLAN
- 2314571: TEVA
- 2324324: RATIOPHARM, TEVA, MYLAN
- 9311920: RATIOPHARM
Unknown/Other
- Infringement – T-1721-03 – T-2025-02 – T-2027-02 – T-2081-02 – T-2082-02 – T-865-02
- Patent Conflict – T-1964-02 – T-2097-02
- Appeal – A-585-06 – A-595-06
- Impeachment – T-341-02 (2006 FC 1465, 2006 FC 1500, 2006 FC 1501)
APOTEX
- Infringement – T-772-09 (2010 FC 633, 2010 FC 968, 2012 FC 1301, 2012 FC 1339)
- PM(NOC) – A-58-07 (2007 FCA 195) – T-1314-05 (2007 FC 971) – T-2042-12 – T-2137-04 (2007 FC 26) – T-706-05
- Appeal – A-371-10 (2011 FCA 77) – A-484-07 (2009 FCA 8) – A-560-12 (2014 FCA 13)
MINT
- PM(NOC) – T-1817-11
MYLAN
- PM(NOC) – T-139-10
NOVOPHARM
- Appeal – A-292-09 (2010 FCA 242) – A-348-08 (2008 FCA 263, 2008 CAF 263)
PHARMASCIENCE
- PM(NOC) – T-1967-08
RATIOPHARM
- PM(NOC) – T-1157-08 – T-1935-08 – T-955-08 (2010 FC 612)
SANDOZ
- PM(NOC) – T-1989-08
TEVA
- PM(NOC) – T-1566-07 (2008 FC 674, 2009 FC 638)
- Section 8 – T-2280-12 (2017 FC 957, 2014 FC 69)
- Appeal – A-154-15 (2015 FCA 280) – A-538-14 (2015 FCA 257) – A-93-14 (2014 FCA 138)
Return to the Patented Medicine Litigation page.